The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B

Hepatology

Volumn 61, Issue 4, 2015, Pages 1251-1260

  Peng, Liang ^a   Zhao, Qiang ^b   Li, Qibin ^c   Li, Miaoxin ^d   Li, Caixia ^a   Xu, Tingting ^e   Jing, Xiangyi ^b,f   Zhu, Xiang ^a   Wang, Ye ^b   Li, Fucheng ^b   Liu, Ruihong ^b   Zhong, Cheng ^b,g   Pan, Qihao ^b   Zeng, Binghui ^b   Liao, Qijun ^c   Hu, Bin ^b   Hu, Zhao xia ^a   Huang, Yang su ^a   Sham, Pak ^d   Liu, Jinsong ^e   Xu, Shuhua ^h   Wang, Jun ^c,d,i,j   Gao, Zhi liang ^a   Wang, Yiming ^b,c   more..

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c BGI SHENZHEN   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^f Guangzhou Women and Children's Medical Center   (China)

^g HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

^h INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; SODIUM BILE ACID COTRANSPORTER; COTRANSPORTER; ORGANIC ANION TRANSPORTER; SODIUM-BILE ACID COTRANSPORTER;

ACUTE ON CHRONIC LIVER FAILURE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXOME; FEMALE; FOLLOW UP; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAN CHINESE; HEPATITIS B; HERITABILITY; HUMAN; INFECTION RESISTANCE; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ADULT; GENETICS; MIDDLE AGED;

ADULT; FEMALE; GENETIC ASSOCIATION STUDIES; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; SYMPORTERS;

EID: 84925352043     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27608     Document Type: Article

References (41)

1. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009;3:269-282.
2. Kim TY, Kim DJ. Acute-on-chronic liver failure. Clin Mol Hepatol 2013;19:349-359.
3. Lu FM, Zhuang H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J (Engl) 2009;122:2925-2927.
4. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 1984;52:396-402.
5. Marsh M, Helenius A. Virus entry: open sesame. Cell 2006;124:729-740.
6. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012;1:e49.
7. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002;64:635-661.
8. Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004;126:322-342.
9. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 2014;146:1070-1083.
10. Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. J Hepatol 2014;60:723-731.
11. Watashi K, Sluder A, Daito T, Matsunaga S, Ryo A, Nagamori S, et al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology 2014;59:1726-1737.
12. Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem Biophys Res Commun 2014;443:808-813.
13. Seeger C, Mason WS. Sodium-dependent taurocholic cotransporting polypeptide: a candidate receptor for human hepatitis B virus. Gut 2013;62:1093-1095.
14. Yan H, Peng B, Liu Y, Xu G, He W, Ren B, et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J Virol 2014;88:3273-3284.
15. +-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations. Xenobiotica 2011;41:501-510.
16. Li N, Zhang P, Yang C, Zhu Q, Li Z, Li F, et al. Association of genetic variation of sodium taurocholate cotransporting polypeptide with chronic hepatitis B virus infection. Genet Test Mol Biomarkers 2014;18:425-429.
17. Su Z, Li Y, Liao Y, Cai B, Chen J, Zhang J, et al. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population. Infect Genet Evol 2014;27:77-82.
18. Li LM, ed. Epidemiology. Beijing: People's Medical Publishing; 2003.
19. Wu CG, Han KE, Shao XP, Shu J, Lin YJ, Zhang JK, et al. Sero-epidemiological study on hepatitis B virus infection in Guangdong Province. Chin Prev Med 2009:350-354.
20. Zhao Q, Peng L, Huang W, Li Q, Pei Y, Yuan P, et al. Rare inborn errors associated with chronic hepatitis B virus infection. Hepatology 2012;56:1661-1670.
21. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). [in Chinese] Zhonghua Liu Xing Bing Xue Za Zhi 2011;32:405-415.
22. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011;12:745-755.
23. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754-1760.
24. +-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem 2003;279:7213-7222.
25. Xu S, Yin X, Li S, Jin W, Lou H, Yang L, et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet 2009;85:762-774.
26. Qin P, Li Z, Jin W, Lu D, Lou H, Shen J, et al. A panel of ancestry informative markers to estimate and correct potential effects of population stratification in Han Chinese. Eur J Hum Genet 2013;22:248-253.
27. Zhou X, Levin EJ, Pan Y, McCoy JG, Sharma R, Kloss B, et al. Structural basis of the alternating-access mechanism in a bile acid transporter. Nature 2013;505:569-573.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. Plink: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
29. Wallenstein S, Wittes J. The power of the Mantel-Haenszel test for grouped failure time data. Biometrics 1993;49:1077-1087.
30. Liu I-M. Breslow-Day Test. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. 2nd ed. Hoboken, NJ: Wiley, 2005.
31. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
32. So H, Gui AHS, Cherny SS, Sham PC. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 2011;35:310-317.
33. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-893.
34. Harrell . Regression Modeling Strategies. New York: Springer-Verlag; 2011:501-507.
35. Hu N, Iwata S, Cameron AD, Drew D. Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature 2011;478:408-411.
36. Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 2003;1609:1-18.
37. Ballatori N, Christian WV, Lee JY, Dawson PA, Soroka CJ, Boyer JL, et al. OSTα-OSTβ: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 2005;42:1270-1279.
38. Lindenbach BD, Rice CM. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 2013;11:688-700.
39. Baumert TF, Meredith L, Ni Y, Felmlee DJ, McKeating JA, Urban S. Entry of hepatitis B and C viruses-recent progress and future impact. Curr Opin Virol 2014;4:58-65.
40. Vaz FM, Paulusma CC, Huidekoper H, de Ru M, Lim C, Koster J, et al. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype. Hepatology 2014; doi: 10.1002/hep.27240.
41. Lempp FA, Urban S. Inhibitors of hepatitis B virus attachment and entry. Intervirology 2014;57:151-157.